Show simple item record

dc.rights.licenseopenen_US
hal.structure.identifierNeurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB]
dc.contributor.authorBELLOCCHIO, Luigi
hal.structure.identifierNeurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB]
dc.contributor.authorMARSICANO, Giovanni
dc.date.accessioned2023-03-28T16:36:11Z
dc.date.available2023-03-28T16:36:11Z
dc.date.created2022
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/172643
dc.description.abstractEnCognitive dysfunction is often diagnosed in people with obesity and associated metabolic disorders. In the latest issue of Cell Metabolism, Ramírez et al. highlight an impaired production of the neurosteroid pregnenolone in the hypothalamus as a mechanism for obesity-induced cognitive impairment in both rodent models and patients with obesity.
dc.description.sponsorshipDissection des mécanismes hypothalamiques impliqués dans la détection du statut nutritionnel et régulation de la prise alimentaire via les interactions entre mTORC1, les mélanocortines et les endocannabinoïdes. - ANR-13-BSV4-0006en_US
dc.description.sponsorshipReprésentation sensorielle lors d'états psychotiques - ANR-16-CE37-0010en_US
dc.description.sponsorshipRole du recepteur CB1 mitocondriel du tissue adipeux dans la regulation de la balance energetiqueen_US
dc.description.sponsorshipBordeaux Region Aquitaine Initiative for Neuroscience - ANR-10-LABX-0043en_US
dc.language.isoENen_US
dc.subject.enPregnenolone
dc.subject.enComplication
dc.subject.enHuman
dc.subject.enHypothalamus
dc.subject.enObesity
dc.subject.enHumans
dc.title.enForgetting in obesity: The pregnenolone link
dc.title.alternativeCell Metaben_US
dc.typeDocument de travail - Pré-publicationen_US
dc.identifier.doi10.1016/j.cmet.2022.01.006en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed35108507en_US
dc.description.sponsorshipEuropeNeurocircuitry of endocannabinoid regulation of food intakeen_US
dc.description.sponsorshipEuropeDevelopment of pregnenolone derivatives as allosteric inhibitors of CB1 cannabinoid receptors for thetreatment of schizophrenia and psychotic syndromesen_US
bordeaux.page187en_US
bordeaux.hal.laboratoriesNeurocentre Magendie - U1215en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamEndocannabinoïdes et Neuroadaptationen_US
bordeaux.identifier.funderIDFondation pour la Recherche Médicaleen_US
bordeaux.identifier.funderIDHuman Frontier Science Programen_US
bordeaux.identifier.funderIDConseil Régional Aquitaineen_US
hal.identifierhal-04049696
hal.version1
hal.date.transferred2023-03-28T16:36:14Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.spage=187&rft.epage=187&rft.au=BELLOCCHIO,%20Luigi&MARSICANO,%20Giovanni&rft.genre=preprint


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record